Company news

Clinuvel Pharmaceuticals Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

FDA allows US clinical trials of afamelanotide in EPP

February 10, 2016

FDA allows Clinuvel`s innovative vitiligo trial

February 10, 2016

European Commission approves SCENESSE

February 10, 2016

Encouraging interim safety results in Phase II OTR study

February 10, 2016

Clinuvel unveils SCENESSE following European brand approval

February 10, 2016

Clinuvel to start a Phase II vitiligo study in Singapore

February 10, 2016

Clinuvel Strategic Update

February 10, 2016

Clinuvel receives an unsolicited bid for the Company

February 10, 2016

Clinuvel Newsletter - February 2012

February 10, 2016

Clinuvel, FDA agree in principle to Phase III study

February 10, 2016

Clinuvel announces innovative melanocortin

February 10, 2016

Clinical significance and benefit from SCENESSE in US Phase

February 10, 2016

Appendix 4C

February 10, 2016

← Newer news releases

Calls

Decks

The 5 newest of 62 decks. Every deck is listed under its year.